D. VURALLI BAKKALOĞLU Et Al. , "THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY," 28th EUROPEAN CONGRESS OF PATHOLOGY , vol.469, KÖLN, Germany, pp.34-35, 2016
VURALLI BAKKALOĞLU, D. Et Al. 2016. THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY. 28th EUROPEAN CONGRESS OF PATHOLOGY , (KÖLN, Germany), 34-35.
VURALLI BAKKALOĞLU, D., ŞENTÜRK ÇİFTÇİ, H., MÜSLÜMANOĞLU, Ö., EKİZOĞLU ERATAK, S., ÇINAR, Ç., AR, M. C., ... TÜZÜNER, N.(2016). THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY . 28th EUROPEAN CONGRESS OF PATHOLOGY (pp.34-35). KÖLN, Germany
VURALLI BAKKALOĞLU, Doğu Et Al. "THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY," 28th EUROPEAN CONGRESS OF PATHOLOGY, KÖLN, Germany, 2016
VURALLI BAKKALOĞLU, Doğu V. Et Al. "THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY." 28th EUROPEAN CONGRESS OF PATHOLOGY , KÖLN, Germany, pp.34-35, 2016
VURALLI BAKKALOĞLU, D. Et Al. (2016) . "THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY." 28th EUROPEAN CONGRESS OF PATHOLOGY , KÖLN, Germany, pp.34-35.
@conferencepaper{conferencepaper, author={Doğu VURALLI BAKKALOĞLU Et Al. }, title={THE INCIDENCE & PROGNOSTIC IMPACT OF ASXL1 MUTATIONS/ PROTEIN EXPRESSION IN MYELOID STEM CELL DISEASES WITH CONCURRENT BONE MARROW FIBROSIS AND CONCORDANCE BETWEEN SANGER SEQUENCING & IMMUNOHISTOCHEMISTRY}, congress name={28th EUROPEAN CONGRESS OF PATHOLOGY}, city={KÖLN}, country={Germany}, year={2016}, pages={34-35} }